89854-97-7 Usage
Uses
Used in Organic Synthesis:
3-Methoxycyclohexanamine is utilized as a building block in organic synthesis for the creation of various compounds. Its unique structure allows for the development of a range of chemical entities with diverse applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-Methoxycyclohexanamine is employed as a key intermediate in the synthesis of potential drug candidates. Its ability to be modified and incorporated into complex molecules makes it a valuable asset in drug discovery and development processes.
Used in Investigation of Pharmacological Properties:
3-Methoxycyclohexanamine may possess pharmacological properties that warrant investigation. Researchers may explore its potential therapeutic applications, which could lead to the discovery of new treatments for various conditions.
It is crucial to handle 3-Methoxycyclohexanamine with care due to potential risks and hazards associated with its use. Proper safety measures should be implemented to ensure the safe handling and application of 3-methoxycyclohexanamine in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 89854-97-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,8,5 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 89854-97:
(7*8)+(6*9)+(5*8)+(4*5)+(3*4)+(2*9)+(1*7)=207
207 % 10 = 7
So 89854-97-7 is a valid CAS Registry Number.
89854-97-7Relevant academic research and scientific papers
1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE
-
, (2008/12/04)
Compounds of formula (I) or a salt thereof are provided, wherein R4, R5, R6, Q and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders and cognitive impairments are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.
